These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 19492408)

  • 21. No Touching! Abrasion of Adsorbed Protein Is the Root Cause of Subvisible Particle Formation During Stirring.
    Sediq AS; van Duijvenvoorde RB; Jiskoot W; Nejadnik MR
    J Pharm Sci; 2016 Feb; 105(2):519-529. PubMed ID: 26869415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Remediating agitation-induced antibody aggregation by eradicating exposed hydrophobic motifs.
    Clark RH; Latypov RF; De Imus C; Carter J; Wilson Z; Manchulenko K; Brown ME; Ketchem RR
    MAbs; 2014; 6(6):1540-50. PubMed ID: 25484048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Nanoparticle-Based Assay To Evaluate Surface-Induced Antibody Instability.
    Kopp MRG; Capasso Palmiero U; Arosio P
    Mol Pharm; 2020 Mar; 17(3):909-918. PubMed ID: 31917582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IgG particle formation during filling pump operation: a case study of heterogeneous nucleation on stainless steel nanoparticles.
    Tyagi AK; Randolph TW; Dong A; Maloney KM; Hitscherich C; Carpenter JF
    J Pharm Sci; 2009 Jan; 98(1):94-104. PubMed ID: 18454482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein-associated water and secondary structure effect removal of blood proteins from metallic substrates.
    Anand G; Zhang F; Linhardt RJ; Belfort G
    Langmuir; 2011 Mar; 27(5):1830-6. PubMed ID: 21182242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Linking aggregation and interfacial properties in monoclonal antibody-surfactant formulations.
    Kannan A; Shieh IC; Fuller GG
    J Colloid Interface Sci; 2019 Aug; 550():128-138. PubMed ID: 31055138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Understanding the Increased Aggregation Propensity of a Light-Exposed IgG1 Monoclonal Antibody Using Hydrogen Exchange Mass Spectrometry, Biophysical Characterization, and Structural Analysis.
    Bommana R; Chai Q; Schöneich C; Weiss WF; Majumdar R
    J Pharm Sci; 2018 Jun; 107(6):1498-1511. PubMed ID: 29408480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Impact of the Metal Interface on the Stability and Quality of a Therapeutic Fusion Protein.
    Defante AP; Kalonia CK; Keegan E; Bishop SM; Satish HA; Hudson SD; Santacroce PV
    Mol Pharm; 2020 Feb; 17(2):569-578. PubMed ID: 31917583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A thermal-cycling method for disaggregating monoclonal antibody oligomers.
    Sadavarte RH; Ghosh R
    J Pharm Sci; 2014 Mar; 103(3):870-8. PubMed ID: 24549731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adsorption-induced antigenic changes and their significance in ELISA and immunological disorders.
    Butler JE; Navarro P; Sun J
    Immunol Invest; 1997; 26(1-2):39-54. PubMed ID: 9037611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Formulation design and high-throughput excipient selection based on structural integrity and conformational stability of dilute and highly concentrated IgG1 monoclonal antibody solutions.
    Bhambhani A; Kissmann JM; Joshi SB; Volkin DB; Kashi RS; Middaugh CR
    J Pharm Sci; 2012 Mar; 101(3):1120-35. PubMed ID: 22147527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adsorption behavior of a human monoclonal antibody at hydrophilic and hydrophobic surfaces.
    Couston RG; Skoda MW; Uddin S; van der Walle CF
    MAbs; 2013; 5(1):126-39. PubMed ID: 23196810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subvisible particle counting provides a sensitive method of detecting and quantifying aggregation of monoclonal antibody caused by freeze-thawing: insights into the roles of particles in the protein aggregation pathway.
    Barnard JG; Singh S; Randolph TW; Carpenter JF
    J Pharm Sci; 2011 Feb; 100(2):492-503. PubMed ID: 20803602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanistic Investigation on Grinding-Induced Subvisible Particle Formation during Mixing and Filling of Monoclonal Antibody Formulations.
    Gikanga B; Hui A; Maa YF
    PDA J Pharm Sci Technol; 2018; 72(2):117-133. PubMed ID: 29030532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-throughput screening and stability optimization of anti-streptavidin IgG1 and IgG2 formulations.
    Alekseychyk L; Su C; Becker GW; Treuheit MJ; Razinkov VI
    J Biomol Screen; 2014 Oct; 19(9):1290-301. PubMed ID: 25023322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody adsorption and orientation on hydrophobic surfaces.
    Wiseman ME; Frank CW
    Langmuir; 2012 Jan; 28(3):1765-74. PubMed ID: 22181558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An accelerated surface-mediated stress assay of antibody instability for developability studies.
    Kopp MRG; Wolf Pérez AM; Zucca MV; Capasso Palmiero U; Friedrichsen B; Lorenzen N; Arosio P
    MAbs; 2020; 12(1):1815995. PubMed ID: 32954930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of Protein Conformation, Apparent Solubility, and Protein-Protein Interactions on the Rates and Mechanisms of Aggregation for an IgG1Monoclonal Antibody.
    Kalonia C; Toprani V; Toth R; Wahome N; Gabel I; Middaugh CR; Volkin DB
    J Phys Chem B; 2016 Jul; 120(29):7062-75. PubMed ID: 27380437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlating Surface Activity with Interface-Induced Aggregation in a High-Concentration mAb Solution.
    Escobar ELN; Griffin VP; Dhar P
    Mol Pharm; 2024 Mar; 21(3):1490-1500. PubMed ID: 38385557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surfactant Effects on Particle Generation in Antibody Formulations in Pre-filled Syringes.
    Gerhardt A; Mcumber AC; Nguyen BH; Lewus R; Schwartz DK; Carpenter JF; Randolph TW
    J Pharm Sci; 2015 Dec; 104(12):4056-4064. PubMed ID: 26413998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.